QuidelOrtho Corp (QDEL)
40.14
+2.25
(+5.94%)
USD |
NASDAQ |
Nov 22, 16:00
40.99
+0.85
(+2.12%)
After-Hours: 20:00
QuidelOrtho Free Cash Flow: -96.80M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -96.80M |
| June 30, 2024 | -170.10M |
| March 31, 2024 | -118.80M |
| December 31, 2023 | 70.90M |
| September 30, 2023 | 146.80M |
| June 30, 2023 | 108.50M |
| March 31, 2023 | 388.90M |
| December 31, 2022 | 744.40M |
| September 30, 2022 | 925.70M |
| June 30, 2022 | 936.00M |
| March 31, 2022 | 484.33M |
| December 31, 2021 | 513.10M |
| September 30, 2021 | 634.42M |
| June 30, 2021 | 712.05M |
| March 31, 2021 | 1.017B |
| December 31, 2020 | 564.84M |
| September 30, 2020 | 193.73M |
| June 30, 2020 | 152.40M |
| March 31, 2020 | 134.65M |
| December 31, 2019 | 107.26M |
| September 30, 2019 | 102.45M |
| June 30, 2019 | 117.04M |
| March 31, 2019 | 101.70M |
| December 31, 2018 | 104.66M |
| September 30, 2018 | 76.74M |
| Date | Value |
|---|---|
| June 30, 2018 | 43.53M |
| March 31, 2018 | 15.20M |
| December 31, 2017 | 10.20M |
| September 30, 2017 | 16.29M |
| June 30, 2017 | 23.72M |
| March 31, 2017 | 35.37M |
| December 31, 2016 | -0.094M |
| September 30, 2016 | -1.067M |
| June 30, 2016 | -3.946M |
| March 31, 2016 | -18.65M |
| December 31, 2015 | 19.85M |
| September 30, 2015 | 23.80M |
| June 30, 2015 | 29.78M |
| March 31, 2015 | 35.25M |
| December 31, 2014 | 24.44M |
| September 30, 2014 | 6.162M |
| June 30, 2014 | -2.664M |
| March 31, 2014 | -9.424M |
| December 31, 2013 | 3.181M |
| September 30, 2013 | 14.20M |
| June 30, 2013 | 22.30M |
| March 31, 2013 | 34.90M |
| December 31, 2012 | -8.089M |
| September 30, 2012 | -6.746M |
| June 30, 2012 | -18.78M |
Free Cash Flow Range, Past 5 Years
-170.10M
Minimum
Jun 2024
1.017B
Maximum
Mar 2021
372.45M
Average
291.32M
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 6.486B |
| Becton Dickinson & Co | 3.073B |
| Repligen Corp | 131.26M |
| Perspective Therapeutics Inc | -40.58M |
| Xtant Medical Holdings Inc | -17.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 117.90M |
| Cash from Investing (Quarterly) | -56.50M |
| Cash from Financing (Quarterly) | -26.30M |
| Free Cash Flow Per Share (Quarterly) | 1.061 |
| Free Cash Flow to Equity (Quarterly) | 84.60M |
| Free Cash Flow to Firm (Quarterly) | 105.88M |
| Free Cash Flow Yield | -3.60% |